This market research report includes a detailed segmentation of the global bacterial conjunctivitis drugs market by drug class (fluoroquinolones, aminoglycosides, macrolides, and others). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The top vendors analyzed in this report are Akorn, Alcon, Allergan, and Bausch & Lomb.
Technavio’s market research analysts estimate the global bacterial conjunctivitis drugs market, to grow at a CAGR of around 3% between 2016 and 2020. Bacterial conjunctivitis is an extremely contagious eye condition wherein the conjunctiva is infected. Fluoroquinolones, macrolides, aminoglycosides, and phenicols are among the different classes of antibiotics that are commonly prescribed to treat the condition. The Americas dominate the bacterial conjunctivitis drugs market, owing to the presence of a well-developed healthcare system and the widespread availability of reimbursement facilities in the region.
The new market research report from Technavio provides a breakdown and analysis of the bacterial conjunctivitis drugs segments by technology.
“The development of multi-drug resistant variants has augmented use of drugs in the market. Patients are expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market,” says Imran Mushtaq, Industry Manager, Healthcare & Lifesciences, Technavio Research
The fluoroquinolones segment is expected to dominate the market during the forecast period. The broad spectrum of activity and increased efficacy of these drugs, even at lower concentrations, are the main factors fueling the demand for fluoroquinolones among the consumers.
Global bacterial conjunctivitis drugs market by drug class
Source: Technavio, 2016
The key players in the global bacterial conjunctivitis market are Akorn, Alcon, Allergan, and Bausch & Lomb. The market is highly fragmented because of the presence of numerous small and large vendors. The vendors in this market compete on the basis of price, quality, and innovation. The high level of vendor competition in this market has led to an increase in the number of mergers and acquisitions, wherein smaller entities are being acquired by or are being merged with, major players.
A more detailed analysis is available in the Technavio report, Global Bacterial Conjunctivitis Drugs Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
